Possible use of autologous stem cell therapies for Alzheimer's disease

Current Alzheimer Research

Volumn 2, Issue 3, 2005, Pages 367-376

  Sugaya, Kiminobu ^a,b  

^a UNIVERSITY OF CENTRAL FLORIDA   (United States)

^b UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Amyloid; Bone marrow; Differentiation; Memory; Mesenchimal stem cell; Neuroregeneration; Proliferation; Transplantation

Indexed keywords

AMYLOID PRECURSOR PROTEIN; PYRIMIDINE DERIVATIVE;

ALZHEIMER DISEASE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL PROLIFERATION; COGNITION; CONFERENCE PAPER; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; COGNITION; HUMANS; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSPLANTATION, AUTOLOGOUS;

EID: 22144469750     PISSN: 15672050     EISSN: None     Source Type: Journal    
DOI: 10.2174/1567205054367919     Document Type: Conference Paper

References (101)

1. Alvarez-Buylla A, Kirn JR. Birth, migration, incorporation, and death of vocal control neurons in adult songbirds. J Neurobiol 33:585-601 (1997).
2. Gould E, Reeves AJ, Fallah M, Tanapat P, Gross CG, Fuchs E. Hippocampal neurogenesis in adult Old World primates. Proc Natl Acad Sci U S A 96:5263-7 (1999).
3. Qu T, Brannen CL, Kim HM, Sugaya K. Human neural stem cells improve cognitive function of aged brain. Neuroreport 12:1127-32 (2001).
4. Doetsch F, Caille I, Lim DA, Garcia-Verdugo JM, Alvarez-Buylla A. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 97:703-16 (1999).
5. Johansson CB, Svensson M, Wallstedt L, Janson AM, Frisen J. Neural Stem Cells in the Adult Human Brain. Exp Cell Res 253:733-736 (1999).
6. Johansson CB, Momma S, Clarke DL, Risling M, Lendahl U, Frisen J. Identification of a neural stem cell in the adult mammalian central nervous system. Cell 96:25-34 (1999).
7. Svendsen CN, ter Borg MG, Armstrong RJ, Rosser AE, Chandran S, Ostenfeld T, et al. A new method for the rapid and long term growth of human neural precursor cells. J Neurosci Methods 85:141-52 (1998).
8. Brannen CL, Sugaya K. In vitro differentiation of multipotent human neural progenitors in serum-free medium. Neuroreport 11:1123-8 (2000).
9. Fricker RA, Carpenter MK, Winkler C, Greco C, Gates MA, Bjorklund A. Site-specific migration and neuronal differentiation of human neural progenitor cells after transplantation in the adult rat brain. J Neurosci 19:5990-6005 (1999).
10. Ostenfeld T, Caldwell MA, Prowse KR, Linskens MH, Jauniaux E, Svendsen CN. Human neural precursor cells express low levels of telomerase in vitro and show diminishing cell proliferation with extensive axonal outgrowth following transplantation. Exp Neurol 164:215-26 (2000).
11. Clarkson ED. Fetal tissue transplantation for patients with Parkinson's disease: a database of published clinical results. Drugs Aging 18:773-85 (2001).
12. Majumdar MK, Thiede MA, Mosca JD, Moorman M, Gerson SL. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 176:57-66 (1998).
13. Pereira RF, Halford KW, O'Hara MD, Leeper DB, Sokolov BP, Pollard MD, et al. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci U S A 92:4857-61 (1995).
14. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71-4 (1997).
15. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-7 (1999).
16. Ferrari G, Cusella-De Angelis G, Coletta M, Paolucci E, Stornaiuolo A, Cossu G, et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279:1528-30 (1998).
17. Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H, Pan J, et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103:697-705 (1999).
18. Petersen BE, Bowen WC, Patrene KD, Mars WM, Sullivan AK, Murase N, et al. Bone marrow as a potential source of hepatic oval cells. Science 284:1168-70 (1999).
19. Mackenzie TC, Flake AW. Human mesenchymal stem cells persist, demonstrate site-specific multipotential differentiation, and are present in sites of wound healing and tissue regeneration after transplantation into fetal sheep. Blood Cells Mol Dis 27:601-4 (2001).
20. Imasawa T, Utsunomiya Y, Kawamura T, Zhong Y, Nagasawa R, Okabe M, et al. The potential of bone marrow-derived cells to differentiate to glomerular mesangial cells. J Am Soc Nephrol 12:1401-9 (2001).
21. Liechty KW, MacKenzie TC, Shaaban AF, Radu A, Moseley AM, Deans R, et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 6:1282-6 (2000).
22. Prockop DJ, Azizi SA, Phinney DG, Kopen GC, Schwarz EJ. Potential use of marrow stromal cells as therapeutic vectors for diseases of the central nervous system. Prog Brain Res 128:293-7 (2000).
23. Bianco P, Riminucci M, Gronthos S, Robey PG. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19:180-92 (2001).
24. Schwarz EJ, Alexander GM, Prockop DJ, Azizi SA. Multipotential marrow stromal cells transduced to produce L-DOPA: engraftment in a rat model of Parkinson disease. Hum Gene Ther 10:2539-49 (1999).
25. Chopp M, Zhang XH, Li Y, Wang L, Chen J, Lu D, et al. Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation. Neuroreport 11:3001-5 (2000).
26. Chen J, Li Y, Chopp M. Intracerebral transplantation of bone marrow with BDNF after MCAo in rat. Neuropharmacology 39:711-6 (2000).
27. Li Y, Chopp M, Chen J, Wang L, Gautam SC, Xu YX, et al. Intrastriatal transplantation of bone marrow nonhematopoietic cells improves functional recovery after stroke in adult mice. J Cereb Blood Flow Metab 20:1311-9 (2000).
28. Kopen GC, Prockop DJ, Phinney DG. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci U S A 96:10711-6 (1999).
29. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-9 (2002).
30. Terada N, Hamazaki T, Oka M, Hoki M, Mastalerz DM, Nakano Y, et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416:542-5 (2002).
31. Ying QL, Nichols J, Evans EP, Smith AG. Changing potency by spontaneous fusion. Nature 416:545-8 (2002).
32. Kennea NL, Mehmet H. Neural stem cells. J Pathol 197:536-50 (2002).
33. Galli R, Gritti A, Bonfanti L, Vescovi AL. Neural stem cells: an overview. Circ Res 92:598-608 (2003).
34. Eriksson PS, Perfilieva E, Bjork-Eriksson T, Alborn AM, Nordborg C, Peterson DA, et al. Neurogenesis in the adult human hippocampus. Nat Med 4:1313-7 (1998).
35. Kuhn HG, Dickinson-Anson H, Gage FH. Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation. J Neurosci 16:2027-33 (1996).
36. Gage FH. Mammalian neural stem cells. Science 287:1433-8 (2000).
37. Karishma KK, Herbert J. Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons and prevents corticosterone-induced suppression. Eur J Neurosci 16:445-53 (2002).
38. van Praag H, Schinder AF, Christie BR, Toni N, Palmer TD, Gage FH. Functional neurogenesis in the adult hippocampus. Nature 415:1030-4 (2002).
39. Sommer L, Rao M. Neural stem cells and regulation of cell number. Prog Neurobiol 66:1-18 (2002).
40. Felling RJ, Levison SW. Enhanced neurogenesis following stroke. J Neurosci Res 73:277-83 (2003).
41. Kuhn HG, Dickinson-Anson H, Gage FH. Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation. J Neurosci 16:2027-33 (1996).
42. McEwen BS. Plasticity of the hippocampus: adaptation to chronic stress and allostatic load. Ann N Y Acad Sci 933:265-77 (2001).
43. Jin K, Peel AL, Mao XO, Xie L, Cottrell BA, Henshall DC, et al. Increased hippocampal neurogenesis in Alzheimer's disease. Proc Natl Acad Sci U S A 101:343-7 (2004).
44. Itoh S, Samejima H, Shinomiya K, Awaya A. The effect of neurotrophic pyrimidine heterocyclic compounds, MS-818 and MS-430, on the regeneration of injured peripheral nerves. Restor Neurol Neurosci 14:265-273 (1999).
45. Awaya A, Kobayashi H, Horikomi K, Tanaka S, Kabir AM, Yokoyama K, et al. Neurotropic pyrimidine heterocyclic compounds. I. The newly synthesized pyrimidine compounds promote neurite outgrowth of GOTO and neuro 2a neuroblastoma cell lines, and potentiate nerve growth factor (NGF)-induced neurite sprouting of PC 12 cells. Biol Pharm Bull 16:248-53 (1993).
46. Sanjo N, Owada K, Kobayashi T, Mizusawa H, Awaya A, Michikawa M. A novel neurotrophic pyrimidine compound MS-818 enhances neurotrophic effects of basic fibroblast growth factor. J Neurosci Res 54:604-12 (1998).
47. Torigoe K, Awaya A. A newly synthesized neurotropic pyrimidine compound, MS-818, may activate migratory schwann cells in peripheral nerve regeneration. Brain Res 787:337-40 (1998).
48. Sugiyama N, Yoshimura A, Fujitsuka C, Iwata H, Awaya A, Mori S, et al. Acceleration by MS-818 of early muscle regeneration and enhanced muscle recovery after surgical transection. Muscle Nerve 25:218-29 (2002).
49. Watanabe S, Wang XE, Hirose M, Osada T, Yoshizawa T, Tanaka H, et al. A neurotrophic pyrimidine compound, MS-818, enhances EGF-induced restoration of gastric epithelial wounds in vitro. J Clin Gastroenterol 27 Suppl 1:S105-9 (1998).
50. Martinez-Serrano A, Hantzopoulos PA, Bjorklund A. Ex vivo gene transfer of brain-derived neurotrophic factor to the intact rat forebrain: neurotrophic effects on cholinergic neurons. Eur J Neurosci 8:727-35 (1996).
51. Sinden JD, Stroemer P, Grigoryan G, Patel S, French SJ, Hodges H. Functional repair with neural stem cells. Novartis Found Symp 231:270-83 (2000).
52. Roch JM, Jin LW, Ninomiya H, Schubert D, Saitoh T. Biologically active domain of the secreted form of the amyloid beta/A4 protein precursor. Ann N Y Acad Sci 695:149-57 (1993).
53. Salinero O, Moreno-Flores MT, Wandosell F. Increasing neurite outgrowth capacity of beta-amyloid precursor protein proteoglycan in Alzheimer's disease. J Neurosci Res 60:87-97 (2000).
54. Hayashi Y, Kashiwagi K, Ohta J, Nakajima M, Kawashima T, Yoshikawa K. Alzheimer amyloid protein precursor enhances proliferation of neural stem cells from fetal rat brain. Biochem Biophys Res Commun 205:936-43 (1994).
55. Hoffmann J, Twiesselmann C, Kummer MP, Romagnoli P, Herzog V. A possible role for the Alzheimer amyloid precursor protein in the regulation of epidermal basal cell proliferation. [In Process Citation]. Eur J Cell Biol 79:in basal cells, the growth-promotin (2000).
56. Ohsawa I, Takamura C, Morimoto T, Ishiguro M, Kohsaka S. Amino-terminal region of secreted form of amyloid precursor protein stimulates proliferation of neural stem cells. Eur J Neurosci 11:1907-13 (1999).
57. De Strooper B, Annaert W. Proteolytic processing and cell biological functions of the amyloid precursor protein. J Cell Sci 113:1857-70 (2000).
58. Ando K, Oishi M, Takeda S, Iijima K, Isohara T, Nairn AC, et al. Role of phosphorylation of Alzheimer's amyloid precursor protein during neuronal differentiation. J Neurosci 19:4421-7 (1999).
59. Koszyca B, Blumbergs PC, Manavis J, Wainwright H, James R, Gilbert J, et al. Widespread axonal injury in gunshot wounds to the head using amyloid precursor protein as a marker. J Neurotrauma 15:675-83 (1998).
60. Murakami N, Yamaki T, Iwamoto Y, Sakakibara T, Kobori N, Fushiki S, et al. Experimental brain injury induces expression of amyloid precursor protein, which may be related to neuronal loss in the hippocampus. J Neurotrauma 15:993-1003 (1998).
61. Galli C, Piccini A, Ciotti MT, Castellani L, Calissano P, Zaccheo D, et al. Increased amyloidogenic secretion in cerebellar granule cells undergoing apoptosis. Proc Natl Acad Sci U S A 95:1247-52 (1998).
62. Rohn TT, Ivins KJ, Bahr BA, Cotman CW, Cribbs DH. A monoclonal antibody to amyloid precursor protein induces neuronal apoptosis. J Neurochem 74:2331-42 (2000).
63. Wallace WC, Akar CA, Lyons WE, Kole HK, Egan JM, Wolozin B. Amyloid precursor protein requires the insulin signaling pathway for neurotrophic activity. Brain Res Mol Brain Res 52:213-27 (1997).
64. Wang C, Wurtman RJ, Lee RK. Amyloid precursor protein and membrane phospholipids in primary cortical neurons increase with development, or after exposure to nerve growth factor or Abeta(1-40). Brain Res 865:157-67 (2000).
65. Serby M. Olfaction and Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 10:579-86 (1986).
66. Bacon Moore AS, Paulsen JS, Murphy C. A test of odor fluency in patients with Alzheimer's and Huntington's disease. J Clin Exp Neuropsychol 21:341-51 (1999).
67. Murphy C, Jinich S. Olfactory dysfunction in Down's Syndrome. Neurobiol Aging 17:631-7 (1996).
68. Murphy C. Loss of olfactory function in dementing disease. Physiol Behav 66:177-82 (1999).
69. Crews L, Hunter D. Neurogenesis in the olfactory epithelium. Perspect Dev Neurobiol 2:151-61 (1994).
70. Yi M, Wu P, Trevorrow KW, Claflin L, Garrard WT. Evidence that the Igkappa gene MAR regulates the probability of premature V-J joining and somatic hypermutation. J Immunol 162:6029-39 (1999).
71. Alonso G, Prieto M, Chauvet N. Tangential migration of young neurons arising from the subventricular zone of adult rats is impaired by surgical lesions passing through their natural migratory pathway. J Comp Neurol 405:508-28 (1999).
72. LeBlanc A. Increased production of 4 kDa amyloid beta peptide in serum deprived human primary neuron cultures: possible involvement of apoptosis. J Neurosci 15:7837-46 (1995).
73. Huang HM, Ou HC, Hsieh SJ. Antioxidants prevent amyloid peptide-induced apoptosis and alteration of calcium homeostasis in cultured cortical neurons. Life Sci 66:1879-92 (2000).
74. LeBlanc A, Liu H, Goodyer C, Bergeron C, Hammond J. Caspase-6 role in apoptosis of human neurons, amyloidogenesis, and Alzheimer's disease. J Biol Chem 274:23426-36 (1999).
75. Piccini A, Ciotti MT, Vitolo OV, Calissano P, Tabaton M, Galli C. Endogenous APP derivatives oppositely modulate apoptosis through an autocrine loop. Neuroreport 11:1375-9 (2000).
76. Hugon J, Esclaire F, Lesort M, Kisby G, Spencer P. Toxic neuronal apoptosis and modifications of tau and APP gene and protein expressions. Drug Metab Rev 31:635-47 (1999).
77. Hung AY, Koo EH, Haass C, Selkoe DJ. Increased expression of beta-amyloid precursor protein during neuronal differentiation is not accompanied by secretory cleavage. Proc Natl Acad Sci USA 89:9439-43 (1992).
78. Beckman M, Iverfeldt K. Increased gene expression of beta-amyloid precursor protein and its homologues APLP1 and APLP2 in human neuroblastoma cells in response to retinoic acid. Neurosci Lett 221:73-6 (1997).
79. Kirazov E, Kirazov L, Bigl V, Schliebs R. Ontogenetic changes in protein level of amyloid precursor protein (APP) in growth cones and synaptosomes from rat brain and prenatal expression pattern of APP mRNA isoforms in developing rat embryo. Int J Dev Neurosci 19:287-96 (2001).
80. Ishiguro M, Ohsawa I, Takamura C, Morimoto T, Kohsaka S. Secreted form of beta-amyloid precursor protein activates protein kinase C and phospholipase Cgamma1 in cultured embryonic rat neocortical cells. Brain Res Mol Brain Res 53:24-32 (1998).
81. Ohsawa I, Takamura C, Kohsaka S. Fibulin-1 binds the amino-terminal head of beta-amyloid precursor protein and modulates its physiological function. J Neurochem 76:1411-20 (2001).
82. Greenberg SM, Koo EH, Selkoe DJ, Qiu WQ, Kosik KS. Secreted beta-amyloid precursor protein stimulates mitogen-activated protein kinase and enhances tau phosphorylation. Proc Natl Acad Sci U S A 91:7104-8 (1994).
83. Miyachi T, Asai K, Tsuiki H, Mizuno H, Yamamoto N, Yokoi T, et al. Interleukin-1beta induces the expression of lipocortin 1 mRNA in cultured rat cortical astrocytes. Neurosci Res 40:53-60 (2001).
84. Sorbi S, Forleo P, Nacmias B. Alzheimer's disease: phenotypes and genotypes. Funct Neurol 12:147-51 (1997).
85. Karran EH, Allsop D, Christie G, Davis J, Gray C, Mansfield F, et al. Presenilins-in search of functionality. Biochem Soc Trans 26:491-6 (1998).
86. Clark RF, Hutton M, Talbot C, Wragg M, Lendon C, Busfield F, et al. The role of presenilin 1 in the genetics of Alzheimer's disease. Cold Spring Harb Symp Quant Biol 61:551-8 (1996).
87. Levy-Lahad E, Wijsman EM, Nemens E, Anderson L, Goddard KA, Weber JL, et al. A familial Alzheimer's disease locus on chromosome 1. Science 269:970-3 (1995).
88. Duff K, Eckman C, Zehr C, Yu X, Prada CM, Perez-tur J, et al. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature 383:710-3 (1996).
89. Steiner H, Pesold B, Haass C. An in vivo assay for the identification of target proteases which cleave membrane-associated substrates. FEBS Lett 463:245-9 (1999).
90. Yang X, Handler M, Shen J. Role of presenilin-1 in murine neural development. Ann N Y Acad Sci 920:165-70 (2000).
91. Ray WJ, Yao M, Nowotny P, Mumm J, Zhang W, Wu JY, et al. Evidence for a physical interaction between presenilin and Notch. Proc Natl Acad Sci U S A 96:3263-8 (1999).
92. Schuldt AJ, Brand AH. Mastermind acts downstream of notch to specify neuronal cell fates in the Drosophila central nervous system. Dev Biol 205:287-95 (1999).
93. Bahn S, Mimmack M, Ryan M, Caldwell MA, Jauniaux E, Starkey M, et al. Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Down's syndrome: a gene expression study. Lancet 359:310-5 (2002).
94. Sawa A. Neuronal cell death in Down's syndrome. J Neural Transm Suppl 57:87-97 (1999).
95. Arai Y, Suzuki A, Mizuguchi M, Takashima S. Developmental and aging changes in the expression of amyloid precursor protein in Down syndrome brains. Brain Dev 19:290-4 (1997).
96. Bondolfi L, Calhoun M, Ermini F, Kuhn HG, Wiederhold KH, Walker L, et al. Amyloid-associated neuron loss and gliogenesis in the neocortex of amyloid precursor protein transgenic mice. J Neurosci 22:515-22 (2002).
97. White AR, Zheng H, Galatis D, Maher F, Hesse L, Multhaup G, et al. Survival of cultured neurons from amyloid precursor protein knock-out mice against Alzheimer's amyloid-beta toxicity and oxidative stress. J Neurosci 18:6207-17 (1998).
98. Coulson EJ, Paliga K, Beyreuther K, Masters CL. What the evolution of the amyloid protein precursor supergene family tells us about its function. Neurochem Int 36:175-84 (2000).
99. Wasco W, Bupp K, Magendantz M, Gusela JF, Tanzi RE, Solomon F. Identification of a mouse brain cDNA that encodes a protein related to the Alzheimer disease-associated amyloid beta protein precursor. Proc Natl Acad Sc U S A 89:10758-62 (1992).
100. von Koch CS, Zheng H, Chen H, Trumbauer M, Thinakaran G, van der Ploeg LH, et al. Generation of APLP2 KO mice and early postnatal lethality in APLP2/APP double KO mice. NeurobiolAging 18:661-9 (1997).
101. McNamara MJ, Ruff CT, Wasco W, Tanzi RE, Thinakaran G, Hyman BT. Immunohistochemical and in situ analysis of amyloid precursor-like protein-1 and amyloid precursor-like protein-2 expression in Alzheimer disease and aged control brains. Brain Res 804:45-51 (1998).